Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Author index

Page Path
HOME > Browse articles > Author index
Search
Young Hoon Roh 1 Article
Validation of the 8th AJCC Cancer Staging System for Pancreas Neuroendocrine Tumors Using Korean Nationwide Surgery Database
Yunghun You, Jin-Young Jang, Song Cheol Kim, Yoo-Seok Yoon, Joon Seong Park, Chol Kyoon Cho, Sang-Jae Park, Jae Do Yang, Woo Jung Lee, Tae Ho Hong, Keun Soo Ahn, Chi-Young Jeong, Hyeon Kook Lee, Seung Eun Lee, Young Hoon Roh, Hee Joon Kim, Hongbeom Kim, In Woong Han
Cancer Res Treat. 2019;51(4):1639-1652.   Published online April 19, 2019
DOI: https://doi.org/10.4143/crt.2019.023
AbstractAbstract PDFPubReaderePub
Purpose
The 8th edition of the American Joint Committee on Cancer (AJCC) staging system for pancreatic neuroendocrine tumor (PNET) included several significant changes. We aim to evaluate this staging system compared to the 7th edition AJCC staging system and European Neuroendocrine Tumors Society (ENETS) system.
Materials and Methods
We used Korean nationwide surgery database (2000-2014). Of 972 patients who had undergone surgery for PNET, excluding patients diagnosed with ENETS/World Health Organization 2010 grade 3 (G3), only 472 patients with accurate stage were included.
Results
Poor discrimination in overall survival rate (OSR) was noted between AJCC 8th stage III and IV (p=0.180). The disease-free survival (DFS) curves of 8th AJCC classification were well separated between all stages. Compared with stage I, the hazard ratio of II, III, and IV was 3.808, 13.928, and 30.618, respectively (p=0.007, p < 0.001, and p < 0.001). The curves of OSR and DFS of certain prognostic group in AJCC 7th and ENETS overlapped. In ENETS staging system, no significant difference in DFS between stage IIB versus IIIA (p=0.909) and IIIA versus IIIB (p=0.291). In multivariable analysis, lymphovascular invasion (p=0.002), perineural invasion (p=0.003), and grade (p < 0.001) were identified as independent prognostic factors for DFS.
Conclusion
This is the first large-scale validation of the AJCC 8th edition staging system for PNET. The revised 8th system provides better discrimination compared to that of the 7th edition and ENETS TNM system. This supports the clinical use of the system.

Citations

Citations to this article as recorded by  
  • Prognostic value of CT-based radiomics in grade 1–2 pancreatic neuroendocrine tumors
    Subin Heo, Hyo Jung Park, Hyoung Jung Kim, Jung Hoon Kim, Seo Young Park, Kyung Won Kim, So Yeon Kim, Sang Hyun Choi, Jae Ho Byun, Song Cheol Kim, Hee Sang Hwang, Seung Mo Hong
    Cancer Imaging.2024;[Epub]     CrossRef
  • Contemporary Approaches to the Surgical Management of Pancreatic Neuroendocrine Tumors
    Akash Kartik, Valerie L. Armstrong, Chee-Chee Stucky, Nabil Wasif, Zhi Ven Fong
    Cancers.2024; 16(8): 1501.     CrossRef
  • Optimal surgical management of unifocal vs. multifocal NF-PNETs: a respective cohort study
    Juwan Kim, Seung Soo Hong, Sung Hyun Kim, Ho Kyong Hwang, Chang Moo Kang
    World Journal of Surgical Oncology.2024;[Epub]     CrossRef
  • Venous invasion and lymphatic invasion are correlated with the postoperative prognosis of pancreatic neuroendocrine neoplasm
    Sho Kiritani, Junichi Arita, Yuichiro Mihara, Rihito Nagata, Akihiko Ichida, Yoshikuni Kawaguchi, Takeaki Ishizawa, Nobuhisa Akamatsu, Junichi Kaneko, Kiyoshi Hasegawa
    Surgery.2023; 173(2): 365.     CrossRef
  • Impact of 68Ga-FAPI-04 PET/CT on Staging and Therapeutic Management in Patients With Digestive System Tumors
    Aleksander Kosmala, Sebastian E. Serfling, Wiebke Schlötelburg, Thomas Lindner, Kerstin Michalski, Andreas Schirbel, Takahiro Higuchi, Philipp E. Hartrampf, Andreas K. Buck, Alexander Weich, Rudolf A. Werner
    Clinical Nuclear Medicine.2023; 48(1): 35.     CrossRef
  • Recurrence and outcomes of non‐functional pancreatic neuroendocrine tumours post‐resection: an Australian retrospective, multicentre cohort study
    Sean Lim, Lynn Chong, Saania Peeroo, Olukunle Onasanya, Evelyn He, Simon Banting, Daniel Croagh
    ANZ Journal of Surgery.2023; 93(1-2): 160.     CrossRef
  • Validation of a supplementary condition of eighth AJCC staging system for stage II hepatocellular carcinoma
    Min Li, Linquan Wu, Shuaiwu Luo, Yaran Liu, Chi Sun, Enliang Li, Jiakun Wang, Bowen Li, Zhihao Huang, Jin Ge, Jun Lei, Fan Zhou, Wenjun Liao
    European Journal of Surgical Oncology.2023; 49(7): 1217.     CrossRef
  • A population-based nomogram to individualize treatment modality for pancreatic cancer patients underlying surgery
    Xiao-Ya Shi, Yan Wang, Xuan Zhou, Meng-Li Xie, Qian Ma, Gan-Xin Wang, Jing Zhan, Yi-Ming Shao, Bai Wei
    Scientific Reports.2023;[Epub]     CrossRef
  • Impact of CXCR4-Directed PET/CT on Staging and Proposed Oncologic Management in Patients With Digestive System Tumors
    Alexander Weich, Sebastian E. Serfling, Wiebke Schlötelburg, Takahiro Higuchi, Philipp E. Hartrampf, Andreas Schirbel, Marieke Heinrich, Andreas K. Buck, Steven P. Rowe, Aleksander Kosmala, Rudolf A. Werner
    Clinical Nuclear Medicine.2023; 48(7): 586.     CrossRef
  • Lifestyle, clinical and histological indices-based prediction models for survival in cancer patients: a city-wide prospective cohort study in China
    Ce Sun, Huan Xu, Suixiang Wang, Ke Li, Pengzhe Qin, Boheng Liang, Lin Xu
    Journal of Cancer Research and Clinical Oncology.2023; 149(12): 9965.     CrossRef
  • A Machine Learning Approach Using [18F]FDG PET-Based Radiomics for Prediction of Tumor Grade and Prognosis in Pancreatic Neuroendocrine Tumor
    Yong-Jin Park, Young Suk Park, Seung Tae Kim, Seung Hyup Hyun
    Molecular Imaging and Biology.2023; 25(5): 897.     CrossRef
  • Prognostic validity of the American joint committee on cancer eighth edition staging system for well-differentiated pancreatic neuroendocrine tumors
    Hebin Wang, Ding Ding, Tingting Qin, Hang Zhang, Jun Liu, Junfang Zhao, Chien-Hui Wu, Ammar Javed, Christopher Wolfgang, Shiwei Guo, Qingmin Chen, Weihong Zhao, Wei Shi, Feng Zhu, Xingjun Guo, Xu Li, Feng Peng, Ruizhi He, Simiao Xu, Jikuan Jin, Yi Wu, Abu
    HPB.2022; 24(5): 681.     CrossRef
  • Comparison of oncologic outcomes between open and laparoscopic distal pancreatectomy for pancreatic ductal adenocarcinoma using data from the KOTUS-BP national database: overcoming selection bias and the necessity of definite indications
    Hongbeom Kim, Jin Seok Heo, Chang Moo Kang, Ho Kyoung Hwang, Ho-Seong Han, Yoo-Seok Yoon, Joon Seong Park, Sung-Sik Han, Yong Hoon Kim, Hyeon Kook Lee, Young-Dong Yu, In Seok Choi, Jae Do Yang, Younghoon Roh, Seong-Ryong Kim, Junchul Chung, Sang Hwa Song,
    HPB.2022; 24(10): 1804.     CrossRef
  • Fate of Surgical Patients with Small Nonfunctioning Pancreatic Neuroendocrine Tumors: An International Study Using Multi-Institutional Registries
    In Woong Han, Jangho Park, Eun Young Park, So Jeong Yoon, Gang Jin, Dae Wook Hwang, Kuirong Jiang, Wooil Kwon, Xuefeng Xu, Jin Seok Heo, De-Liang Fu, Woo Jung Lee, Xueli Bai, Yoo-Seok Yoon, Yin-Mo Yang, Keun Soo Ahn, Chunhui Yuan, Hyeon Kook Lee, Bei Sun,
    Cancers.2022; 14(4): 1038.     CrossRef
  • Development and Validation of a Modified Eighth AJCC Staging System for Primary Pancreatic Neuroendocrine Tumors
    Xu-Feng Zhang, Feng Xue, Zheng Wu, Alexandra G. Lopez-Aguiar, George Poultsides, Eleftherios Makris, Flavio Rocha, Zaheer Kanji, Sharon Weber, Alexander Fisher, Ryan Fields, Bradley A. Krasnick, Kamran Idrees, Paula M. Smith, Cliff Cho, Megan Beems, Yi Ly
    Annals of Surgery.2022; 275(6): e773.     CrossRef
  • Pancreatic neuroendocrine neoplasms: survival trend analysis of a comprehensive center
    Sara Coelho, Cláudia Costa, Ana Paula Santos, Pedro Souteiro, Joana Oliveira, Júlio Oliveira, Isabel Azevedo, Isabel Torres, Maria José Bento
    Endocrine Oncology.2022; 2(1): 32.     CrossRef
  • Surgical Outcomes, Long-Term Survivals and Staging Systems of World Health Organization G3 Pancreatic Neuroendocrine Tumors
    Min Yang, Lin Zeng, Shengzhong Hou, Bole Tian, Shuguang Jin, Yi Zhang
    Journal of Clinical Medicine.2022; 11(18): 5253.     CrossRef
  • Development and Validation of Prognostic Nomograms for Periampullary Neuroendocrine Neoplasms: A SEER Database Analysis
    Jinghua Chen, Qichen Chen, Yiqiao Deng, Yujuan Jiang, Zhen Huang, Jianguo Zhou, Hong Zhao, Jianqiang Cai
    Current Oncology.2022; 30(1): 344.     CrossRef
  • Clinical value of 68Ga-DOTA-SSTR PET/CT in the diagnosis and detection of neuroendocrine tumors of unknown primary origin: a systematic review and meta-analysis
    Huan Ma, Ying Kan, Ji-gang Yang
    Acta Radiologica.2021; 62(9): 1217.     CrossRef
  • Surgical Strategy Based on Radiological 3D Reconstruction in a Giant Metastatic Neuroendocrine Tumor of the Pancreas: A Case Report of an Interdisciplinary Approach
    Gabriel Fridolin Hess, Savas Deniz Soysal, Guillaume Nicolas, Martin Bolli, Christoph Johannes Zech, Alexandar Tzankov, Emanuel Christ, Michael Montemurro, Otto Kollmar, Tahsin Colak
    Case Reports in Surgery.2021; 2021: 1.     CrossRef
  • Prognostic significance of extracellular volume fraction with equilibrium contrast-enhanced computed tomography for pancreatic neuroendocrine neoplasms
    Hiromichi Iwaya, Yoshihiko Fukukura, Shinichi Hashimoto, Shiroh Tanoue, Machiko Kawahira, Makoto Hinokuchi, Toshihiro Fujita, Yuga Komaki, Shiho Arima, Fumisato Sasaki, Shuji Kanmura, Michiyo Higashi, Kiichi Tamada, Akio Ido
    Pancreatology.2021; 21(4): 779.     CrossRef
  • The 8th Edition American Joint Committee on Cancer Staging for Hepato-pancreato-biliary Cancer: A Review and Update
    Xiaoyan Liao, Dongwei Zhang
    Archives of Pathology & Laboratory Medicine.2021; 145(5): 543.     CrossRef
  • Insights of Outcome after Resection of Small Nonfunctioning Neuroendocrine Pancreatic Tumors
    Estela Regina Ramos Figueira, Julia Fray Ribeiro, Thiago Costa Ribeiro, Ricardo Jureidini, Guilherme Naccache Namur, Thiago Nogueira Costa, Telesforo Bacchella, Ivan Cecconello, Jose Celso Ardengh
    Gastroenterology Research and Practice.2021; 2021: 1.     CrossRef
  • New staging classification for pancreatic neuroendocrine neoplasms combining TNM stage and WHO grade classification [ ]
    Min Wang, Ding Ding, Tingting Qin, Hebin Wang, Yahui Liu, Jianhua Liu, Jun Liu, Hang Zhang, Junfang Zhao, Chien-Hui Wu, Ammar Javed, Christopher Wolfgang, Shiwei Guo, Qingmin Chen, Weihong Zhao, Wei Shi, Feng Zhu, Xingjun Guo, Xu Li, Ruizhi He, Simiao Xu,
    Cancer Letters.2021; 518: 207.     CrossRef
  • Ampullary Neuroendocrine Tumors: Insight into a Rare Histology
    Samantha M. Ruff, Oliver Standring, Grace Wu, Anna Levy, Sandeep Anantha, Elliot Newman, Martin S. Karpeh, William Nealon, Gary B. Deutsch, Matthew J. Weiss, Danielle K. DePeralta
    Annals of Surgical Oncology.2021; 28(13): 8318.     CrossRef
  • Pancreatic neuroendocrine tumors: A review of serum biomarkers, staging, and management
    Zu-Yi Ma, Yuan-Feng Gong, Hong-Kai Zhuang, Zi-Xuan Zhou, Shan-Zhou Huang, Yi-Ping Zou, Bo-Wen Huang, Zhong-Hai Sun, Chuan-Zhao Zhang, Yun-Qiang Tang, Bao-Hua Hou
    World Journal of Gastroenterology.2020; 26(19): 2305.     CrossRef
  • Functionality is not an independent prognostic factor for pancreatic neuroendocrine tumors
    Hong-Yu Chen, Ya-Liang Zhou, Yong-Hua Chen, Xing Wang, Hao Zhang, Neng-Wen Ke, Xu-Bao Liu, Chun-Lu Tan
    World Journal of Gastroenterology.2020; 26(25): 3638.     CrossRef
  • Pancreatic Neuroendocrine Neoplasms: 2020 Update on Pathologic and Imaging Findings and Classification
    Lokesh Khanna, Srinivasa R. Prasad, Abhijit Sunnapwar, Sainath Kondapaneni, Anil Dasyam, Varaha S. Tammisetti, Umber Salman, Alia Nazarullah, Venkata S. Katabathina
    RadioGraphics.2020; 40(5): 1240.     CrossRef
  • Evaluation of Outcomes Following Surgery for Locally Advanced Pancreatic Neuroendocrine Tumors
    Ashley L. Titan, Jeffrey A. Norton, Andrea T. Fisher, Deshka S. Foster, E. John Harris, David J. Worhunsky, Patrick J. Worth, Monica M. Dua, Brendan C. Visser, George A. Poultsides, Michael T. Longaker, Robert T. Jensen
    JAMA Network Open.2020; 3(11): e2024318.     CrossRef
  • Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies
    Lingaku Lee, Tetsuhide Ito, Robert T Jensen
    Expert Review of Anticancer Therapy.2019; 19(12): 1029.     CrossRef
  • 10,007 View
  • 248 Download
  • 32 Web of Science
  • 30 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP